COMMUNIQUÉS West-GlobeNewswire

Agile Therapeutics to Present at the 2019 BIO CEO and Investor Conference
07/02/2019
PRINCETON, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Chairman and Chief Executive Officer, Al Altomari will present at the [...]
Clinical update: Dovitinib DRP data mining successfully completed and new LiPlaCis data continues to support an FDA breakthrough designation strategy
07/02/2019
Press release Hoersholm, Denmark and Cambridge, MA, US, February 7, 2019 – Oncology Venture A/S (“OV” or “the Company”) today provides a clinical update on its precision drug projects. Oncology Venture has finalized the [...]
ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2018 Earnings Conference Call
07/02/2019
SAN CLEMENTE, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
Moleculin Announces Approval for Third Drug to Commence Clinical Trials
07/02/2019
MBRX will now have three distinctive oncology drugs in clinic in four ongoing clinical trials WP1220, a STAT3 inhibitor, to begin clinical trials in Poland for the treatment of Cutaneous T-Cell Lymphona (“CTCL”), a rare [...]
Meridian Launches New Range of Lyo-Ready PCR Mixes
07/02/2019
CINCINNATI, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that following the successful release of the Lyo-Ready qPCR Mix, Meridian is proud to introduce its next-generation [...]
Tabula Rasa HealthCare Announces Proposed $250 Million Offering of Convertible Notes
07/02/2019
MOORESTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) (“TRHC”) today announced its intention to offer, subject to market and other conditions, $250 million principal amount of [...]
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 14, 2019
07/02/2019
NEWTOWN, Pa., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that fourth [...]
Medtronic Receives FDA Approval on Expanded Indication for Pipeline Flex Embolization Device
07/02/2019
Approval Based on Clinical Data from the PREMIER Trial - New Indication Provides Options for Patients with Small or Medium, Wide-Necked Brain Aneurysms DUBLIN - February 7, 2019 - Medtronic plc (NYSE:MDT) announced [...]
BeiGene to Present at the Guggenheim Healthcare Talks Idea Forum – Oncology Day
07/02/2019
CAMBRIDGE, Mass., and BEIJING, China, Feb. 07, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2018
07/02/2019
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
Anavex Life Sciences Reports Fiscal 2019 First Quarter Financial Results And Provides Clinical Study Updates
07/02/2019
Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing [...]
Ogilvy Health's Mangold and McKenna to be inducted into the Medical Advertising Hall of Fame's Future Famers Program
07/02/2019
PARSIPPANY, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Ogilvy Health ( www.ogilvychww.com ), the health practice of Ogilvy, a WPP company (NASDAQ: WWPGY) ( www.wpp.com ), today announced Brittany Mangold, Account [...]
T2 Biosystems Reports Granting of Inducement Awards
07/02/2019
LEXINGTON, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Merus to Participate in Guggenheim Healthcare Talks Idea Forum
07/02/2019
UTRECHT, Netherlands, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today [...]
Advanced Accelerator Applications Announces Health Canada Approval for Lutathera™, a Treatment for Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)¹
07/02/2019
First ever approved Peptide Receptor Radionuclide Therapy in Canada Neuroendocrine tumors are rare malignancies that affect approximately 12,000-15,000 Canadians 2 SAINT-GENIS-POUILLY, France, Feb. 07, 2019 (GLOBE [...]
AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
07/02/2019
Reaffirms 2019 Financial Guidance and Announces Consolidation of Women’s Health and Maternal Health Sales Forces Conference Call Scheduled for 8:00 a.m. ET Today WALTHAM, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- AMAG [...]
Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual Property
07/02/2019
Mayfield, a women’s health focused drug development company, intends to seek FDA approval for MAY-44 Dyspareunia treatment drug candidate via the 505(b)(2) approval pathway SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- [...]
Solid Biosciences Announces Preliminary SGT-001 Data and Intention to Dose Escalate in IGNITE DMD Clinical Trial for Duchenne Muscular Dystrophy
07/02/2019
- Company expediting planned dose escalation activities - - Low levels of SGT-001 microdystrophin protein detected at the starting dose - - Conference call to be held at 8:30 a.m. ET today - CAMBRIDGE, Mass., Feb. 07, [...]
LHC Group Announces Fourth Quarter 2018 Earnings Release and Conference Call Dates
07/02/2019
LAFAYETTE, La., Feb. 07, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc . (NASDAQ: LHCG) today announced details for the release of its results for the fourth quarter and year ended December 31, 2018. LHC Group plans to issue [...]

Pages